Dr. Ralph Lane Wall Jr., MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 520 Allen Street, Montgomery Memorial Hospital, Troy, NC 27371 Phone: 910-571-5360 |
Scott Jeffrey Denardo, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 522 Allen St Ste 101, Troy, NC 27371 Phone: 910-571-5510 |
Mrs. Elizabeth Renukarani Claudius, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 522 Allen St, Suite 101, Troy, NC 27371 Phone: 910-571-5570 Fax: 910-571-5772 |
News Archive
An eight-year Danish study, which involved more than 2.5 million healthy Danes found there was a higher risk of stroke for those taking high doses of ibuprofen, which is in the painkiller Nurofen. The manufacturers of Nurofen, Reckitt Benckiser, have dismissed these reports. The spokesperson for the company said, "it is important to note that the conclusions drawn by the study authors are based on high doses of ibuprofen…The results of this study should not be confused with non-prescription low doses of NSAIDs, such as ibuprofen, which are available over-the-counter and used by millions of people around the world, for short periods of time, every day."
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., and Seattle Genetics, Inc. today announced interim data from a phase I clinical trial evaluating ASG-5ME for the treatment of castration-resistant prostate cancer.
The Wall Street Journal: "Three leading health-care providers in Colorado's Front Range region recently teamed up in an electronic health-record exchange program that will allow them to share data on more than a million Colorado residents. … The three [health systems] have agreed to share their records on a secure network that will allow clinics, doctors' offices and hospitals to exchange data on common patients instantly, including lab reports, radiology images and medical history" (Landro, 4/13).
Twins may look alike on the outside, but not so much on the inside. That's one takeaway from a new preprint study posted to the medRxiv server where Brazilian researchers observed different T-cell responses in two pairs of identical twins exposed to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). One twin who was reinfected with SARS-CoV-2 four months after had low recognition of CD4+ and CD8+ T-cell epitopes.
› Verified 7 days ago